Cat: IPD-X39277

Recombinant Human SETBP1 Protein,His & GST

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    SETBP1

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    SEB

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N- His & GST

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q9Y6X0

  • 表达区间

    Gly1297~Pro1596

  • 分子量

    55kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

SETBP1 (SET Binding Protein 1) is a gene located on chromosome 18 that encodes a protein involved in various cellular processes, including transcription regulation and chromatin remodeling. Recent studies have highlighted its significant role in both normal development and pathological conditions, particularly in myeloid malignancies like chronic myeloid leukemia (CML) and acute myeloid leukemia (AML). Mutations in SETBP1 are increasingly recognized as potential driver mutations that contribute to the development and progression of these cancers. The presence of SETBP1 mutations is associated with poor prognosis and increased treatment resistance, underscoring the need for further research into its functional implications. Given its critical involvement in hematopoiesis and leukemogenesis, the recombinant expression of SETBP1 protein is essential for understanding its biochemical properties and interactions with other cellular factors. Through the generation of recombinant SETBP1 protein, researchers aim to elucidate its mechanisms of action, identify potential interacting partners, and explore its role as a therapeutic target. This work has the potential to provide valuable insights into the molecular underpinnings of SETBP1-related disorders, paving the way for the development of novel therapeutic strategies aimed at targeting its dysregulation in disease contexts.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US